Emergence of untreatable, multidrug-resistant HIV-1 in patients failing second-line therapy in Kenya

被引：14

作者：

Inzaule, Seth C. ^{[1
,2
,3
]}

Hamers, Raph L. ^{[1
,2
,4
]}

Mukui, Irene ^{[5
]}

Were, Kennedy ^{[3
]}

Owiti, Prestone ^{[3
]}

Kwaro, Daniel ^{[3
]}

de Wit, Tobias F. Rinke ^{[1
,2
]}

Zeh, Clement ^{[6
]}

机构：

[1] Acad Med Ctr, Dept Global Hlth, Amsterdam, Netherlands

[2] Amsterdam Inst Global Hlth & Dev, Pietersbergweg 17, NL-1105 BM Amsterdam, Netherlands

[3] Kenya Govt Med Res Ctr, Kisumu, Kenya

[4] Univ Amsterdam, Acad Med Ctr, Div Infect Dis, Dept Internal Med, Amsterdam, Netherlands

[5] Natl AIDS & STI Control Programme, Nairobi, Kenya

[6] US Ctr Dis Control & Prevent, Kisumu, Kenya

来源：

AIDS | 2017年 / 31卷 / 10期

关键词：

ANTIRETROVIRAL DRUG-RESISTANCE; ADULTS;

D O I：

10.1097/QAD.0000000000001500

中图分类号：

R392 [医学免疫学]; Q939.91 [免疫学];

学科分类号：

100102 ;

摘要：

We performed a countrywide assessment of HIV drug resistance among 123 patients with virological failure on second-line antiretroviral therapy (ART) in Kenya. The percentage of patients harbouring intermediate-to-high-level resistance was 27% for lopinavir-ritonavir, 24% for atazanavir-ritonavir and 7% for darunavir-ritonavir, and 25% had complete loss of activity to all available first and second-line drugs. Overall, one in four patients failing second-line ART have completely exhausted available antiretrovirals in Kenya, highlighting the need for increased access to third-line drugs.

引用

页码：1495 / 1498

页数：4

共 50 条

[1] HIV-1 Drug Resistance and Third-Line Therapy Outcomes in Patients Failing Second-Line Therapy in Zimbabwe
Chimbetete, Cleophas
Katzenstein, David
Shamu, Tinei
Spoerri, Adrian
Estill, Janne
Egger, Matthias
Keiser, Olivia
[J]. OPEN FORUM INFECTIOUS DISEASES, 2018, 5 (02):
[2] Resistance to second-line drugs in multidrug-resistant tuberculosis
Udwadia, Zarir
[J]. LANCET, 2013, 381 (9867): : 625 - 626
[3] Multidrug-resistant HIV-1 - Reply
Gandhi, RT
[J]. CLINICAL INFECTIOUS DISEASES, 2004, 38 (10) : 1512 - 1512
[4] Resistance to second-line drugs in multidrug-resistant tuberculosis Reply
Dalton, Tracy
Cegielski, Peter
Kurbatova, Ekaterina
Ershova, Julia
Campos Caoili, Janice
[J]. LANCET, 2013, 381 (9867): : 626 - 626
[5] Antiretroviral Resistance patterns in HIV-1 infected patients failing to second-line in Bamako, Mali
Maiga, A. I.
Traore, F. T.
Dolo, O.
Togo, J.
Calvez, V.
Katlama, C.
Marcelin, A-G
[J]. HIV MEDICINE, 2019, 20 : 175 - 176
[6] Microbicides for multidrug-resistant and multitropic HIV-1
D'Cruz, Osmond J.
Uckun, Fatih M.
[J]. CURRENT OPINION IN INVESTIGATIONAL DRUGS, 2008, 9 (02) : 152 - 169
[7] Standardised second-line treatment of multidrug-resistant tuberculosis during pregnancy
Tabarsi, P.
Moradi, A.
Baghaei, P.
Marjani, M.
Shamaei, M.
Mansouri, N.
Chitsaz, E.
Farnia, P.
Mansouri, D.
Masjedi, M.
Velayati, A.
[J]. INTERNATIONAL JOURNAL OF TUBERCULOSIS AND LUNG DISEASE, 2011, 15 (04) : 547 - 550
[8] HIV-1 drug resistance and third-line outcomes among children and adolescents failing second-line therapy in Malawi
Lee, L.
Mbingwani, I.
Kalua, T.
Spiers, S.
Duranti, S.
Schramm, B.
Kamba, R.
Szumilin, E.
Salumu, L.
Maman, D.
[J]. JOURNAL OF THE INTERNATIONAL AIDS SOCIETY, 2019, 22 : 83 - 83
[9] Antiviral activity of lamivudine in salvage therapy for multidrug-resistant HIV-1 infection
Campbell, TB
Shulman, NS
Johnson, SC
Zolopa, AR
Young, RK
Bushman, L
Fletcher, CV
Lanier, ER
Merigan, TC
Kuritzkes, DR
[J]. CLINICAL INFECTIOUS DISEASES, 2005, 41 (02) : 236 - 242
[10] Viral escape in the CNS with multidrug-resistant HIV-1
Beguelin, Charles
Vazquez, Miriam
Bertschi, Manuel
Yerly, Sabine
de Jong, Denise
Rauch, Andri
Cusini, Alexia
[J]. JOURNAL OF THE INTERNATIONAL AIDS SOCIETY, 2014, 17 : 156 - 157

← 1 2 3 4 5 →